The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
スポンサーリンク
概要
- 論文の詳細を見る
Developing effective drug therapies for arrhythmic diseases is hampered by the fact that the same drug can work well in some individuals but not in others. Human induced pluripotent stem (iPS) cells have been vetted as useful tools for drug screening. However, cardioactive drugs have not been shown to have the same effects on iPS cell-derived human cardiomyocytes as on embryonic stem (ES) cell-derived cardiomyocytes or human cardiomyocytes in a clinical setting. Here we show that current cardioactive drugs affect the beating frequency and contractility of iPS cell-derived cardiomyocytes in much the same way as they do ES cell-derived cardiomyocytes, and the results were compatible with empirical results in the clinic. Thus, human iPS cells could become an attractive tool to investigate the effects of cardioactive drugs at the individual level and to screen for individually tailored drugs against cardiac arrhythmic diseases.
論文 | ランダム
- 廃糖密の発酵生成物の減水剤としての利用-1,2-
- 側頭骨亜全摘の実際
- 両側同時子宮外妊娠の一例
- クレオソート油から誘導される界面活性剤とその応用
- 後天性乳幼期トキソプラスマ症に関する実験病理学的研究-1・2-